Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Specimen Handling 265 Magnetic Resonance Spectroscopy 216 pembrolizumab 212 Carboplatin 173 Biopsy 162 Cisplatin 155 Nivolumab 147 Cyclophosphamide 131 Paclitaxel 116 Radiotherapy 115 Gemcitabine 110 Bevacizumab 91 durvalumab 84 Dexamethasone 79 Rituximab 74 Oxaliplatin 71 atezolizumab 67 Fluorouracil 66 Doxorubicin 65 Capecitabine 65 Docetaxel 64 venetoclax 63 Etoposide 63 Radiosurgery 58 Radiation 57 Prednisone 55 Ipilimumab 55 Cytarabine 55 Pemetrexed 54 Lenalidomide 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thoracic Surgical Procedures × 90 days × Clear all

NCT03872661 2026-04-21

NIBCUN

Sun Yat-sen University

Phase 2 Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡